Clinical Trials Directory

Trials / Terminated

TerminatedNCT02875704

Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy

Status
Terminated
Phase
Study type
Observational
Enrollment
77 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to controls.

Detailed description

People with Stargardt disease, age related macular degeneration (AMD) and diabetic retinopathy (DR) have decrease in central vision from damage to photoreceptors. One of the mechanisms causing damage is high levels of oxygen in the eye. This damage produces specific biomarkers that can be measured in eye fluid (aqueous humor). In this study, these biomarkers will be assessed in people with Stargardt disease, age related macular degeneration and diabetic retinopathy, compared to controls.

Conditions

Interventions

TypeNameDescription
OTHERAnterior Chamber (AC) TapAqueous Samples will be collected for measurement of biomarkers

Timeline

Start date
2017-01-03
Primary completion
2022-06-06
Completion
2022-09-22
First posted
2016-08-23
Last updated
2022-09-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02875704. Inclusion in this directory is not an endorsement.